Minireviews
Copyright ©2014 Baishideng Publishing Group Inc.
World J Transl Med. Aug 12, 2014; 3(2): 112-118
Published online Aug 12, 2014. doi: 10.5528/wjtm.v3.i2.112
Table 1 Comparison between the prostate, lung, colorectal and ovarianand European randomized study of screening for prostate cancer trials
ParticipantsPLCO
ERSPC
ScreeningControlScreeningControl
Age55-74 yr55-69 yr
Contamination rates40% (1st year) to 52% (subsequent years)15%
Total38343383507289089353
Cancer incidence3452 (9%)2974 (7.75%)5990 (8.2%)4307 (4.8%)
Cancer mortality9282214326